Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Upgrade Ecommerce Trust to next level by Blockchain and InsurTech



Reading Time: 3 minutes


Hong Kong Federation of E-Commerce (HKFEC) reached a strategic cooperation agreement with Dowsure Technologies Co., Ltd. (Dowsure) to integrate blockchain technology and consumer insurance to Hong Kong Trust Mark, and to build a trustworthy cross-border e-commerce environment for Hong Kong retailers, at the conference held at Trade & Industry Department (TID)’s Support and Consultation Centre for SMEs today.

Hong Kong Trust Mark was launched by the Federation in 2016 to tackle disputes raised on IP rights, integrity, trust over marketplaces, and to strengthen confidence level for all people shop online with Hong Kong merchants. The trust mark scheme was launched to provide guidance and assistance for Hong Kong online merchants over domestic and cross-border trade. In 2019, there are over 1,000 online merchants using Hong Kong Trustmark to provide a product guarantee to consumers. To further enhance the scheme and provide immediate protection to consumer, HKFEC has formed a strategic partnership with Dowsure Technologies to provide insurance service by well-known insurance companies such as, China Insurance, PICC, CPIC…etc., over Blockchain technology to further protect consumers and sellers from unnecessary loss or damage occurred in every online transaction.

Mr. Joseph Yuen, Chairman of HKFEC said, “We are excited to work with Dowsure to enhance Hong Kong Trust Mark to the next level. Hong Kong has advantage to be a trusted FinTech and InsurTech hub over Greater Bay Area. We are glad to leverage the InsurTech solution by Dowsure for a secure blockchain insurance service for ecommerce merchants with many great insurance companies. It certainly proofs to the world again that Hong Kong has the capability to lead in a healthy digital development as a Smart City.”

Dowsure was established in 2016, as a leading insurtech company in China, is now building a secure and trustworthy insurance and services network for the global cross-border e-commerce. Dowsure creates the solution of “Protection for Global Ecommerce”, through the analysis and research on the whole cross-border e-commerce, dividing the industry into different sections to analyze the risk, probability of risk occurrence and the sustainability. Dowsure designs insurance products based on big data, uses AI technology for actuarial science, controlling risks and pricing, traces information and guarantees products quality by blockchain technology, develops the traditional insurance into “digital insurance” through insurtech and cooperate with insurance companies for product supervision. The innovative solution protects the whole process of massive, fragmented and short-term orders of cross-border e-commerce (import & export). Therefore, Dowsure’s solution solves the problems of fake product and the lack of consumers’ rights protection, lead a positive development of cross-border e-commerce.

Mr. Byron Pei, Founder and CEO of Dowsure said, “E-commerce in Hong Kongshows great prospects for development, however due to the complexity of cross-border e-commerce levels, counterfeit and shoddy goods perplex the consumers and sellers. HKFEC is very authoritative around Hong Kong e-commerce, we are very honored to work with HKFEC and to create a better and safer environment for Hong Kong cross-border e-commerce.

China being the largest Ecommerce market in the world, both seller and consumer have big concerns in trust. In the sellers’ point of view, they have difficulties to proof themselves a valid source for genuine product with good quality. This damage the reputation and customer satisfaction, which causes some international brand hesitated to develop ecommerce in Hong Kong and China market. From the consumer perspective, No.1 concern is getting fake product online, and once that happened, they do not know who responsible for the claim. Therefore, HKFEC and Dowsure aims at protecting consumer rights and privacy, strengthening confidence level of consumer by recruiting brand retailers joining the scheme, all purchase from that particular brand will then be insured by large insurance company.

By utilizing blockchain technology, information including product origin, ordering, logistics arrangement, product receipt, complaints and claims, can be checked by sellers and consumers with a dedicated key. Sellers or consumers can insure for their transaction, if there are any problems arise, consumers are entitled to claims backed by renowned insurance companies such as China Insurance, PICC, CPIC and so on. HKFEC as an organization representing the industry, will continue to actively promote FinTech and e-commerce in the digital economy. The scheme will first launch for local and cross-border e-commerce players in Hong KongMacau and mainland, and gradually expand to other regions.


SOURCE Hong Kong Federation of E-Commerce

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading